Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.19
-0.01
(-6.95%)
After-Hours: 04:52
Tonix Pharmaceuticals Gross Profit Margin (Quarterly): 44.90% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 44.90% |
| June 30, 2024 | -52.49% |
| March 31, 2024 | 33.12% |
| Date | Value |
|---|---|
| December 31, 2023 | 37.36% |
| September 30, 2023 | 40.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-52.49%
Minimum
Jun 2024
44.90%
Maximum
Sep 2024
20.68%
Average
37.36%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 56.80% |
| Geovax Labs Inc | -- |
| Abbott Laboratories | 55.83% |
| Amicus Therapeutics Inc | 90.62% |
| United Therapeutics Corp | 88.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -150.0% |
| Return on Assets | -113.8% |
| Return on Invested Capital | -139.4% |
| Profit Margin (Quarterly) | -503.6% |
| Operating Margin (Quarterly) | -492.1% |
| Return on Net Operating Assets | -140.1% |